BAG6 is a novel player in controlling nonalcoholic steatohepatitis: result from a comprehensive in-silico study
Sarmah, D. T.; Paul, A.; Berry, U.; Surjit, M.; Bairagi, N.; Chatterjee, S.
Show abstract
Nonalcoholic steatohepatitis, or NASH, is a multifactorial disease characterized by hepatic lipid accumulation, inflammation, cell death, and fibrosis, and an efficacious pharmaceutical intervention for this is yet to be discovered. The present study aims to identify potential targets capable of reversing the disease-specific molecular alterations and elucidate their possible action mechanism. Our study uses combinations of different methods, such as genome-scale metabolic modelling, directional protein-protein interaction network, connectivity map, and network controllability, to identify potential targets in NASH. Our approach yielded three promising targets, BAG6, CASP3, and CYCS, and captured their effects on inflammation, fibrosis, steatosis, and apoptosis. The association of CASP3 and CYCS with NASH are already reported in the literature. So BAG6 was selected as a novel target. In the Huh-7 cell-line, its ablation reduced fatty acid accumulation and decreased levels of NASH-signature transcripts, supporting our hypothesis on BAG6 as a potential NASH target.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Disrupted Post-Transcriptional Regulation of Gene Expression as A Hallmark of Fatty Liver Progression 95%
- Vagus nerve mediated liver-brain axis is a major regulator of the metabolic landscape in the liver 94%
- Perturbation of transmembrane 6 superfamily member 2 expression alters lipid metabolism in a human liver cell line 93%
Similar papers in this journal
- Emergent properties of HNF4α-PPARγ network may drive consequent phenotypic plasticity in NAFLD 95%
- Integrative systems biology approach identified crucial genes and transcription factors associated with gallbladder cancer pathogenesis 92%
- Polycystic ovary syndrome susceptibility loci inform disease etiological heterogeneity 90%
Similar papers in this journal
Similar papers in this journal
- Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease 96%
- REV-ERB Agonism Improves Liver Pathology in a Mouse Model of NASH 94%
- Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats 93%
Similar papers in this journal
- Deletion of Mcpip1 in Mcpip1AlbKO mice recapitulates the phenotype of human primary biliary cholangitis 92%
- Hepatic HKDC1 Deletion Alleviates Western Diet-Induced MASH in Mice 92%
- G6PD deficiency mediated impairment of iNOS and lysosomal acidification affecting phagocytotic clearance in microglia in response to SARS-CoV-2 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.